1h Free Analyst Time
The spasticity treatment market is forecasted to grow by USD 1.26 billion during 2024-2029, accelerating at a CAGR of 4.3% during the forecast period. The report on the spasticity treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing incidence of chronic diseases and health conditions, availability of advanced technologies for drug delivery, and introduction of botulinum toxins and cannabinoids.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The spasticity treatment market is segmented as below:
By Type
- Drug therapy
- Physical therapy
- Surgical treatment
By End-user
- Hospitals
- Ambulatory surgical centers
- Home care settings
- Specialty clinics
- Diagnostic centers
By Indication
- Cerebral palsy
- Multiple sclerosis
- Traumatic brain injury
- Others
By Route Of Administration
- Oral
- Parenteral
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the spasticity treatment market covers the following areas:
- Spasticity Treatment Market sizing
- Spasticity Treatment Market forecast
- Spasticity Treatment Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Type
9 Market Segmentation by End-user
10 Market Segmentation by Indication
11 Market Segmentation by Route of Administration
12 Customer Landscape
13 Geographic Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global spasticity treatment market: Abbott Laboratories, Axonics Inc., BioWave Ltd., Boston Scientific Corp., BrainsWay Ltd., electroCore Inc., LivaNova PLC, Mayo Foundation for Medical Education and Research, Medtronic Plc, NEURONETICS Inc., Nevro Corp., OMRON Corp., PathMaker Neurosystems Inc., Rady Children's Hospital-San Diego, Saebo, Saluda Medical Pty Ltd., ShiraTronics, The Johns Hopkins Health System Corp., Theranica Bio Electronics Ltd., and Thync Global Inc..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is advent of neurostimulation devices for spasticity treatment."
According to the report, one of the major drivers for this market is the growing incidence of chronic diseases and health conditions.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- Axonics Inc.
- BioWave Ltd.
- Boston Scientific Corp.
- BrainsWay Ltd.
- electroCore Inc.
- LivaNova PLC
- Mayo Foundation for Medical Education and Research
- Medtronic Plc
- NEURONETICS Inc.
- Nevro Corp.
- OMRON Corp.
- PathMaker Neurosystems Inc.
- Rady Children's Hospital–San Diego
- Saebo
- Saluda Medical Pty Ltd.
- ShiraTronics
- The Johns Hopkins Health System Corp.
- Theranica Bio Electronics Ltd.
- Thync Global Inc.
